We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Investing.com -- PolyPeptide Group AG on Monday reported revenue of €389 million for the financial year 2025, representing a growth rate of 15.6% compared to the previous year.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
PolyPeptide Group AG engages in the business of development, manufacturing, and marketing of peptide- and oligonucleotide-based compounds for use in the pharmaceutical and related research industries.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results